When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Repligen (NASDAQ:RGEN) launched three advanced affinity chromatography resins for use in gene therapy manufacturing workflows. The company said the resins — AVIPure - AAV9, AVIPure - AAV8, and AVIPure - AAV2 — were developed by its unit Avitide, and are specific to the major adeno-associated virus (AAV) gene therapy vectors used today. AAV vectors are the leading platform for gene delivery for treating a variety of human diseases.